Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Glatiramer acetate in the treatment of multiple sclerosis
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US (MANAGE)
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis.
URMC rheumatologist presents data showing drug’s potential to ease arthritis symptoms
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Santhera Announces Successful Outcome of Phase III Study with Catena®/Raxone® in Duchenne Muscular Dystrophy
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis.
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
Pregnancy outcomes in patients exposed to interferon beta-1b.
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-β Therapy in Multiple Sclerosis.
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Individual axons regulate the myelinating potential of single oligodendrocytes in vivo.
Fingolimod Impedes Schwann Cell-Mediated Myelination: Implications for the Treatment of Immune Neuropathies?Effect of Fingolimod on Schwann Cells.
Ofatumumab Dose-finding in RRMS Patients
IgE-Mediated Allergic Reactions after the First Administration of Glatiramer Acetate in Patients with Multiple Sclerosis.
Arzerra
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
Mechanical environment modulates biological properties of oligodendrocyte progenitor cells.
LKB1-regulated adaptive mechanisms are essential for neuronal survival following mitochondrial dysfunction.

Pages